Basel Medical Group Ltd is a holding company, which operates through its subsidiary, Basel Medical Group Pte. Ltd. It provides a wide spectrum of general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Its orthopedic treatments and surgery include non-surgical treatments, such as medications, injections, splinting and physiotherapy, and surgical orthopedic procedures, including minimally invasive treatments for complex surgeries. Its rehabilitative therapy provides in-house physiotherapy treatments, including post-surgery rehabilitation, as well as sports therapy. Its neurosurgical care covers treatments involving spinal and brain conditions, from headaches and brain tumors to spinal issues, aneurysms and strokes. It also specializes in diagnostic imaging and outpatient care.
BörsenkürzelBMGL
Name des UnternehmensBasel Medical Group Ltd
IPO-datumFeb 25, 2025
CEOChhoa (Yen Feng)
Anzahl der mitarbeiter77
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 25
Addresse600 North Bridge Road, #12-02/03
Stadt
BörseNASDAQ OMX - NASDAQ BASIC
LandSingapore
Postleitzahl188778
Telefon6562919188
Websitehttps://www.baselmedical.com
BörsenkürzelBMGL
IPO-datumFeb 25, 2025
CEOChhoa (Yen Feng)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten